Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway.
Saved in:
| Title: | Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway. |
|---|---|
| Authors: | Jiang, Zhixiong1,2 (AUTHOR), Yang, Yating1,2 (AUTHOR), Zhou, Jinchi3 (AUTHOR), Li, Xin4 (AUTHOR), Meng, Qingqing1 (AUTHOR), Yu, Xiangyi1 (AUTHOR), Xue, Yaxin1 (AUTHOR), Li, Mengyu1 (AUTHOR), Cai, Yichen1 (AUTHOR), Han, Pengchun1 (AUTHOR), Jiang, Mingjun1 (AUTHOR), Wang, Huizhen1 (AUTHOR), Liu, Congrong1 (AUTHOR), Zhao, Jing1,2 (AUTHOR) zhaojing_hena@163.com, Wan, Lixin5 (AUTHOR) nanyang1967@163.com, Bao, Dengke1,2,6 (AUTHOR) dengkebao@henu.edu.cn |
| Source: | Journal of Translational Medicine. 6/17/2025, Vol. 23 Issue 1, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
